Postoperative hypoxaemic acute respiratory failure after neoadjuvant treatment for lung cancer: radiologic findings and risk factors.
Marco MammanaNicolò SellaChiara GiraudoVincenzo VerzelettiAnna CarereAlessandro BonisStefano SilvestrinGiorgia PacchiariniTommaso PettenuzzoEleonora MonacoGiulia LorenzoniPaolo NavalesiFederico ReaPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
hARF is the main cause of major morbidity and mortality after neoadjuvant therapy and surgery for NSCLC and occurs more frequently after complex and lengthier surgical procedures. Overall, our findings suggest that operative time may represent the most important risk factor for hARF.
Keyphrases
- respiratory failure
- rectal cancer
- extracorporeal membrane oxygenation
- risk factors
- mechanical ventilation
- locally advanced
- lymph node
- small cell lung cancer
- minimally invasive
- patients undergoing
- coronary artery bypass
- acute respiratory distress syndrome
- squamous cell carcinoma
- stem cells
- radiation therapy
- replacement therapy
- combination therapy
- coronary artery disease
- mesenchymal stem cells
- hepatitis b virus
- bone marrow
- drug induced
- smoking cessation